ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT05879913
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT05879913
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05879913. Randomized; no masking; primary purpose diagnostic. Start 2023-12-15 (actual); primary completion 2027-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
- Condition
- Prostate Cancer
- Intervention (Device)
- Coronary CT Angiography (CCTA)
- Lead sponsor
- Indiana University
- Collaborator
- National Comprehensive Cancer Network
- Collaborator
- Pfizer
- Collaborator
- Sumitomo Pharma America, Inc.
Record details
- Record id
cardio:ct-nct05879913- Content hash
c0f21fb0b4f7ae67e44193083299234485d518daa09252149000df1ce09c5675